Advancing
clinical
outcomes and
improving
patient quality
of life

Based on the principles of angioplasty, iTrack^™ is an implant-free glaucoma surgery that combines 360-degree catheterization with viscodilation to mechanically remove blockages and to dilate Schlemm’s canal in order to remove outflow resistance — achieving excellent clinical outcomes while also preserving the viability of subsequent glaucoma treatments.

The ground-breaking iTrack™ Advance is advancing canaloplasty to the next level. Developed out of extensive research, innovation and feedback from surgeons, iTrack™ Advance takes the established effectiveness,^1,2 accuracy and reliability of the original iTrack™ canaloplasty microcatheter, and combines it with an ergonomic, easy-to-use handheld injector.

1. Gallardo MJ. 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma. 2022 Feb 17:S2589-4196(22)00025 – 4.2.
2 Khaimi, M. A., Dvorak, J. D., & Ding, K. (2017). An analysis of 3‑year outcomes following canaloplasty for the treatment of open-angle glaucoma. Journal of ophthalmology, 2017.

The Molteno3® Glaucoma Drainage Device is designed to enhance surgical utility and optimize clinical outcomes for long-term IOP control in cases of severe and complex glaucoma, with the added benefit of a simplified surgical procedure.